LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

Inicio・Lista de Acciones・Schrodinger Inc

Schrodinger Inc

Cerrado

SectorSanidad

13.24 0.68

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

13.06

Máximo

13.79

Métricas clave
By Trading Economics
Ingresos	-196M -60M
Ventas	-29M 59M
BPA	-0.62
Margen de beneficios	-102.456
Empleados	850
EBITDA	-85M -49M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+42.97% upside

Dividendos
By Dow Jones
Próximas Ganancias	5 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	30M 994M
Apertura anterior	12.56
Cierre anterior	13.24

Noticias sobre sentimiento de mercado

By Acuity

52%

48%

246 / 344 Clasificación en Healthcare

Schrodinger Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 may 2026, 21:33 UTC

Ganancias

Correction to Salesforce 1Q Sales, Profit Rise Article

27 may 2026, 21:00 UTC

Adquisiciones, fusiones, absorciones

HCA Healthcare Agrees to Buy The College of Health Care Professions

27 may 2026, 20:18 UTC

Ganancias

Salesforce 1Q Sales, Profit Rise Amid Agentforce Efforts

27 may 2026, 23:49 UTC

Charlas de Mercado

Nikkei Might Decline Amid Uncertainty Over Potential U.S.-Iran Peace Deal -- Market Talk

27 may 2026, 23:39 UTC

Charlas de Mercado

Congo Copper, Cobalt Mining Not yet Seen Affected by Ebola Outbreak -- Market Talk

27 may 2026, 23:34 UTC

Charlas de Mercado

Infratil's Longroad Energy Considers Data-Center Strategy -- Market Talk

27 may 2026, 23:34 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

27 may 2026, 23:08 UTC

Charlas de Mercado

Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk

27 may 2026, 22:21 UTC

Charlas de Mercado

Salesforce Lays Out AI Monetization Strategy -- Market Talk

27 may 2026, 21:29 UTC

Acciones populares

Stocks to Watch: Marvell Technology, PDD, Zscaler -- WSJ

27 may 2026, 21:08 UTC

Ganancias

Marvell's Data-Center Boom Powers Earnings Beat. Its Stock Surges. -- Barrons.com

27 may 2026, 21:02 UTC

Ganancias

Salesforce Stock Slides on Mixed Results. CFO Touts New Pricing Model. -- Barrons.com

27 may 2026, 20:59 UTC

Adquisiciones, fusiones, absorciones

What to Know About Pasqal, the Quantum Start-Up Going Public Soon -- Barrons.com

27 may 2026, 20:55 UTC

Ganancias

Snowflake Stock Jumps 34%. How Amazon and an Earnings Beat Are Fueling the Gains. -- Barrons.com

27 may 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

27 may 2026, 20:48 UTC

Ganancias

Marvell's Data-Center Boom Powers Earnings Beat -- and a Big Stock Surge -- Barrons.com

27 may 2026, 20:45 UTC

Ganancias

Marvell Stock Jumps on Earnings. Data-Center Revenue Is Still Booming. -- Barrons.com

27 may 2026, 20:34 UTC

Adquisiciones, fusiones, absorciones

Webster Financial Stockholders Approve Sale to Banco Santander

27 may 2026, 20:32 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Synopsys Shares Fall Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

27 may 2026, 20:32 UTC

Adquisiciones, fusiones, absorciones

HCA Healthcare to Acquire The College of Health Care Professions for Undisclosed Terms >HCA

27 may 2026, 20:32 UTC

Adquisiciones, fusiones, absorciones

HCA Healthcare: Eric Bing Will Continue to Lead CHCP as Chancellor and CEO >HCA

27 may 2026, 20:30 UTC

Ganancias

Snowflake Beats Expectations and Expands AWS Ties Amid Software Sector Turmoil -- Barrons.com

27 may 2026, 20:30 UTC

Adquisiciones, fusiones, absorciones

HCA Healthcare Announces Agreement To Acquire The College Of Health Care Professions >HCA

27 may 2026, 20:22 UTC

Ganancias

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 may 2026, 20:16 UTC

Ganancias

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 may 2026, 20:13 UTC

Ganancias

Synopsys Sees 3Q Adj EPS $3.63-Adj EPS $3.69 >SNPS

27 may 2026, 20:13 UTC

Ganancias

Marvell Revenue Beats Estimates. The Stock Rises. -- Barrons.com

27 may 2026, 20:13 UTC

Ganancias

Synopsys Sees FY Adj EPS $14.72-Adj EPS $14.80 >SNPS

27 may 2026, 20:12 UTC

Ganancias

Synopsys Sees FY EPS $2.49-EPS $2.91 >SNPS

27 may 2026, 20:12 UTC

Ganancias

Synopsys Sees 3Q EPS 84c-EPS 98c >SNPS

Comparación entre iguales

Cambio de precio

Schrodinger Inc previsión

Precio Objetivo

By TipRanks

42.97% repunte

Estimación a 12 Meses

Media 18.8 USD 42.97%

Máximo 24 USD

Mínimo 13 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Schrodinger Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Schrodinger Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

246 / 344 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.